Strategic Prevention Framework for Prescription Drugs (SPF Rx)

Forms and Documents

Forms and supporting documents for this ICR

Document	Type	Status	Availability
Form Grantee-Level Inte Grantee-Level Interview	Form and Instruction	Modified	Available
Form Annual Reporting T Annual Reporting Tool	Form and Instruction	Modified	Available
Form Community-Level PD Community-Level PDMP Outcomes Module	Form and Instruction	Modified	Available
Form Grantee-Level PDMP Grantee-Level PDMP Outcomes Module	Form and Instruction	Modified	Available
SPF-Rx Annual Reporting Tool TrackChanges 2-13-23.docx	Supplementary Document	Uploaded 2023-02-14	Repair queued
SPF-Rx Annual Reporting Tool CLEAN-2-13-2023.docx	Supplementary Document	Uploaded 2023-02-14	Available
SPF-Rx Memo_No Material or Nonsubstantive Change.docx	Justification for No Material/Nonsubstantive Change	Uploaded 2023-02-14	Available
SPF Rx Supporting Statement A_final.docx	Supporting Statement A	Uploaded 2026-02-12	Available
Attachment 4 SPF-RX Grantee Interview Track Changes.docx	Supplementary Document	Uploaded 2022-11-04	Available
Attachment 3 SPF-Rx Community-Level PDMP Outcomes Module Track Changes.docx	Supplementary Document	Uploaded 2022-11-04	Available
Attachment 2 SPF-Rx Grantee-Level PDMP Outcomes Module Track Changes.docx	Supplementary Document	Uploaded 2022-11-04	Available
Attachment 1_SPF-Rx Annual Reporting Tool 05.31.2022 Tracked Changes.docx	Supplementary Document	Uploaded 2022-11-04	Available
PD Interview Constructs Outline.docx	Supplementary Document	Uploaded 2022-11-04	Available
SPF Rx Supporting Statement B_2025_final.docx	Supporting Statement B	Uploaded 2026-02-12	Available
Attachment 5_SPF-Rx Summary of Changes to the OMB Pkg_11.21.2019.docx	Supplementary Document	Uploaded 2020-05-11	Available

IC Document Collections

Information collection document groups

IC ID	Collection	Type	Status	Form
241788	Grantee Interview	Form and Instruction	Modified	Grantee-Level Interview
241788	Grantee Interview	Form and Instruction	Modified
241787	Annual Reporting Tool	Form and Instruction	Modified	Annual Reporting Tool
241787	Annual Reporting Tool	Form and Instruction	Modified
241773	Community-Level PDMP Outcomes Module	Form and Instruction	Modified	Community-Level PDMP Outcomes Module
241773	Community-Level PDMP Outcomes Module	Form and Instruction	Modified
241772	Grantee-Level PDMP Outcomes Module	Form and Instruction	Modified	Grantee-Level PDMP Outcomes Module
241772	Grantee-Level PDMP Outcomes Module	Form and Instruction	Modified

ICR Details

OMB Control No: 0930-0377	ICR Reference No: 202602-0930-002
Status: Received in OIRA	Previous ICR Reference No: 202302-0930-002
Agency/Subagency: HHS/SAMHSA	Agency Tracking No:
Title: Strategic Prevention Framework for Prescription Drugs (SPF Rx)
Type of Information Collection: Extension without change of a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular	Date Submitted to OIRA: 02/17/2026

table that charts list comparision

	Requested	Previously Approved
Expiration Date	36 Months From Approved	04/30/2026
Responses	322	275
Time Burden (Hours)	476	713
Cost Burden (Dollars)	0	0

---

Abstract: The SPF-Rx program is designed to address nonmedical use of prescription drugs as well as opioid overdoses by raising awareness about the dangers of sharing medications and by working with pharmaceutical and medical communities. The SPF-Rx program aims to promote collaboration between states/tribes and pharmaceutical and medical communities to understand the risks of overprescribing to youth age 12–17 and adults 18 years of age and older and enhance capacity for and access to Prescription Drug Monitoring Program (PDMP) data for prevention purposes.

---

Authorizing Statute(s): US Code: 42 USC 516 Name of Law: Healthy Pople 2020 Substance Abuse Yopic Area HP 2020-SA
  

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	90 FR 52412	11/20/2025
30-day Notice:	Federal Register Citation:	Citation Date:
	91 FR 5776	02/09/2026
Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 4

table that charts list of burden

IC Title	Form No.	Form Name
Annual Reporting Tool	Annual Reporting Tool	Annual Reporting Tool
Community-Level PDMP Outcomes Module	Community-Level PDMP Outcomes Module	Community-Level PDMP Outcomes Module
Grantee Interview	Grantee-Level Interview	Grantee-Level Interview
Grantee-Level PDMP Outcomes Module	Grantee-Level PDMP Outcomes Module	Grantee-Level PDMP Outcomes Module

---

ICR Summary of Burden

table that charts list of burden

	Total Request	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	322	275	0	47	0	0
Annual Time Burden (Hours)	476	713	0	-237	0	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: Yes

Burden Increase Due to: Miscellaneous Actions

Burden decreases because of Program Change due to Agency Discretion: Yes

Burden Reduction Due to: Miscellaneous Actions

Short Statement: Changes to the instruments have been made to align with the research questions for the PEPC evaluation, which differ from the previous SPF Rx evaluation to focus on current priority of SAMHSA. In addition, changes were made to reduce burden on individual respondents by eliminating overlap with other data collections and to enhance data quality and allow for more in-depth analyses.

---

Annual Cost to Federal Government: $1,052,934

Does this IC contain surveys, censuses, or employ statistical methods? No

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination.     No

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination.     No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? No

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 02/17/2026

---